In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic response at one year ...

During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...

Spain’s Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the dermatological area for Almirall’s psoriasis and atopic ...

Tuesday closed up +0.11%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.52%, and the Nasdaq 100 Index ($IUXX) ...

Ireland has Europe's biggest trade surplus with the US. So Trump's plans to slash corporate tax, onshore multinationals and impose tariffs could hit Ireland hard.

Shareholders request Human Rights Due Diligence to determine whether pharma companies do everything they can to increase drug ...

Eli Lilly partners with VC to launch 700 billion won biotech ecosystem fund Eli Lilly collaborates with a16z to create a vast ...

Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over competitors’ more frequent regimens.

With the close of 2024 and the launch of a new year, we can take a moment to look back at what was another eventful, ...

Meta, Amazon Web Services, Novo Nordisk, xAI took top honors in Business Facilities’ 2024 Deal Of The Year Awards, ...

The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic ...